CMK Corporation provided consolidated earnings guidance for the year ending March 31, 2024. For the year, the company expects net sales of JPY 85,000 million, operating profit of JPY 2,700 million, profit attributable to owners of parent of JPY 1,900 million and basic earnings per share of JPY 32.09.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
624 JPY | +2.97% | +4.70% | -24.82% |
02-28 | Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis; Down 1.8% | MT |
02-28 | Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.82% | 262M | |
+9.85% | 53.68B | |
-16.47% | 14.79B | |
+13.54% | 11.02B | |
+5.97% | 8.92B | |
+24.55% | 8.7B | |
+44.03% | 8.31B | |
-9.56% | 8.12B | |
-14.29% | 6.93B | |
-12.10% | 6.92B |
- Stock Market
- Equities
- 6958 Stock
- News CMK Corporation
- CMK Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024